Intracellular regulation of the renal-tubular oxalate transport - a new key to the pathogenesis of calcium oxalate stones

2002 ◽  
Vol 1 (1) ◽  
pp. 81
Author(s):  
Michael Straub ◽  
Josephine Befolo-Elo ◽  
Richard Hautmann ◽  
Edgar Braendle
Keyword(s):  
Calcium Oxalate ◽  
Calcium Oxalate Stones ◽  
Intracellular Regulation ◽  
Renal Tubular ◽  
Oxalate Transport

scholarly journals Sat1 is dispensable for active oxalate secretion in mouse duodenum

2012 ◽  
Vol 303 (1) ◽  
pp. C52-C57 ◽  
Author(s):  
Narae Ko ◽  
Felix Knauf ◽  
Zhirong Jiang ◽  
Daniel Markovich ◽  
Peter S. Aronson
Keyword(s):  
Calcium Oxalate ◽  
Basolateral Membrane ◽  
Complete Removal ◽  
Calcium Oxalate Stones ◽  
Anion Transporter ◽  
Oxalate Secretion ◽  
In Series ◽  
Disulfonic Stilbene ◽  
Oxalate Transport

Mice deficient for the apical membrane oxalate transporter SLC26A6 develop hyperoxalemia, hyperoxaluria, and calcium oxalate stones due to a defect in intestinal oxalate secretion. However, the nature of the basolateral membrane oxalate transport process that operates in series with SLC26A6 to mediate active oxalate secretion in the intestine remains unknown. Sulfate anion transporter-1 (Sat1 or SLC26A1) is a basolateral membrane anion exchanger that mediates intestinal oxalate transport. Moreover, Sat1-deficient mice also have a phenotype of hyperoxalemia, hyperoxaluria, and calcium oxalate stones. We, therefore, tested the role of Sat1 in mouse duodenum, a tissue with Sat1 expression and SLC26A6-dependent oxalate secretion. Although the active secretory flux of oxalate across mouse duodenum was strongly inhibited (>90%) by addition of the disulfonic stilbene DIDS to the basolateral solution, secretion was unaffected by changes in medium concentrations of sulfate and bicarbonate, key substrates for Sat1-mediated anion exchange. Inhibition of intracellular bicarbonate production by acetazolamide and complete removal of bicarbonate from the buffer also produced no change in oxalate secretion. Finally, active oxalate secretion was not reduced in Sat1-null mice. We conclude that a DIDS-sensitive basolateral transporter is involved in mediating oxalate secretion across mouse duodenum, but Sat1 itself is dispensable for this process.

scholarly journals Urinary stone composition analysis and clinical characterization of 1520 patients in central China

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Daling Zhang ◽  
Songchao Li ◽  
Zhengguo Zhang ◽  
Ningyang Li ◽  
Xiang Yuan ◽  
...  
Keyword(s):  
Calcium Oxalate ◽  
Urinary Stone ◽  
Geographic Region ◽  
Central China ◽  
Urinary Stones ◽  
Composition Analysis ◽  
Stone Composition ◽  
Calcium Oxalate Stones ◽  
Significant Difference ◽  
Lower Urinary

AbstractA total of 1520 patients with urinary stones from central China were collected and analysed by Fourier transform infrared spectroscopy between October 1, 2016 and December 31, 2019. For all patients, age, sex, comorbidities, stone location, laboratory examination and geographic region were collected. The most common stone component was calcium oxalate (77.5%), followed by calcium phosphate (8.7%), infection stone (7.6%), uric acid (UA) stone (5.3%)and cystine (0.9%). The males had more calcium oxalate stones (p < 0.001), while infection stone and cystine stones occurred more frequently in females (p < 0.001). The prevalence peak occurred at 41–60 years in both men and women. UA stones occurred frequently in patients with lower urinary pH (p < 0.001), while neutral urine or alkaline urine (p < 0.001) and urinary infection (p < 0.001) were more likely to be associated with infection stone stones. Patients with high levels of serum creatinine were more likely to develop UA stones (p < 0.001). The proportion of UA stones in diabetics was higher (p < 0.001), and the incidence of hypertension was higher in patients with UA stones (p < 0.001). Compared to the other types, more calcium oxalate stones were detected in the kidneys and ureters (p < 0.001), whereas struvite stones were more frequently observed in the lower urinary tract (p = 0.001). There was no significant difference in stone composition across the Qinling-Huaihe line in central China except UA stones, which were more frequently observed in patients south of the line (p < 0.001).

The Relation between the Concentration of Calcium Salts in the Urine and Renal Stone Composition in Patients with Calcium-Containing Renal Stones

1972 ◽  
Vol 43 (3) ◽  
pp. 433-441 ◽  
Author(s):  
R. W. Marshall ◽  
M. Cochran ◽  
W. G. Robertson ◽  
A. Hodgkinson ◽  
B. E. C. Nordin
Keyword(s):  
Calcium Phosphate ◽  
Calcium Oxalate ◽  
Renal Stones ◽  
Urine Ph ◽  
Stone Composition ◽  
Calcium Oxalate Stones ◽  
Urine Oxalate ◽  
The Difference ◽  
Normal Urine ◽  
Normal Men

1. Diurnal variations in urine calcium oxalate and calcium phosphate activity products were observed in normal men and patients with recurrent calcium oxalate or mixed oxalate—phosphate renal stones. 2. Maximum and minimum calcium oxalate products were higher in the patients than in the controls, the difference being most marked in the patients with calcium oxalate stones. 3. Maximum and minimum calcium phosphate products expressed as octocalcium phosphate [(Ca8H2(PO4)6], brushite or hydroxyapatite, were significantly higher than normal in the patients with mixed stones but not in the patients with calcium oxalate stones. 4. The raised calcium oxalate products in the patients were due mainly to increased concentrations of Ca2+ ions; these, in turn, were due mainly to an increased rate of excretion of calcium. Raised calcium phosphate products were due mainly to hypercalciuria, combined with abnormally high urine pH values. 5. Patients with recurrent calcium stones appear to fall into two types: (1) patients with calcium oxalate stones associated with hypercalciuria, a normal or raised urine oxalate and a normal urine pH; (2) patients with mixed oxalate—phosphate stones associated with hypercalciuria, a normal or raised urine oxalate and a raised urine pH. 6. The implications of these findings in regard to treatment are discussed.

2060 DIETARY OXALATE: WHAT'S IMPORTANT AND WHAT ISN'T FOR PATIENTS WITH CALCIUM OXALATE STONES?

2011 ◽  
Vol 185 (4S) ◽  
Author(s):  
Kristina L. Penniston ◽  
Katrina F. Wojciechowski ◽  
Stephen Y. Nakada
Keyword(s):  
Calcium Oxalate ◽  
Calcium Oxalate Stones ◽  
Dietary Oxalate
Sign in / Sign up

Export Citation Format

Share Document